"AVM II will have a more regional investment approach and will target early stage projects in countries that are within the Pacific Alliance."
In Conversation
"Our country is made up of 60 percent water and 40 percent land and we have more than a thousand islands. With such a geographical structure,…
"The market for anti-cancer treatments for animals, particularly companion animals like dogs and cats, has huge potential and is at this point really an undeveloped, blue…
"Our mission is clear cut: to help either individual patients or couples conceive."
Interview: Johnsee Lee PhD – Founder, President & CEO, Personal Genomics / Quark Biosciences, Taiwan

"In the grand scheme of things, my vision is to make genome sequencing and its applications more widely available and affordable to patients around the world."
"Value-based healthcare is about addressing the inefficiencies we see in the system. There must be incentives for professionals to seek efficiencies and act in the interest…
"Current research sites display a clear lack of quality, especially when put in contrast with the international standards held by large pharmaceutical companies. Catering to improving…
"After 21 years of serving the industry, the backbone that really drove us to establish Foresee was purely based on science."
"We are continuously dealing with the private industry and we obviously check that all companies that are working with us are fully complying with the national…
"We recently started to implement precision medicine into our hospital strategy. However, it is still in the development stage."
"Currently, our focus areas are the complications of diabetes, including kidney and heart complication, as well as renal injury."
"Thus, the national health insurance has been intensively evolving since its creation and different stakeholders have been involved in the transformation to ensure a proper evolution."